Gallbladder cancer – no improvement in survival over time in a Swedish population-Reference-Cited by-同舟云学术

Gallbladder cancer – no improvement in survival over time in a Swedish population

Published:2018-06-22 Issue:11 Volume:57 Page:1482-1489
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Lindnér Per¹,Holmberg Erik²^ORCID,Hafström Lo¹

Affiliation:

1. Transplant Institute, Institute of Clinical Sciences Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden;

2. Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2018.1478124

Reference19 articles.

1. Gallbladder Cancer in the 21st Century

2. National Trends in the Management and Survival of Surgically Managed Gallbladder Adenocarcinoma Over 15 years: A Population-Based Analysis

3. Current Management of Gallbladder Carcinoma

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preoperatively suspected gallbladder cancer improves survival compared with incidental gallbladder cancer in pT3 patients;Scandinavian Journal of Surgery;2024-07-26

2. Preoperative clinical radiomics model based on deep learning in prognostic assessment of patients with gallbladder carcinoma;2024-01-15

3. Effect of different lymph node dissection methods on the number of lymph nodes detected and prognosis in gallbladder cancer;Medicine;2023-06-30

4. Preoperative Fibrinogen Albumin Ratio is an Effective Biomarker for Prognostic Evaluation of Gallbladder Carcinoma After Radical Resection: A 10-Year Retrospective Study at a Single Center;Journal of Inflammation Research;2023-02

5. Fibrinogen promotes gallbladder cancer cell metastasis and extravasation by inducing ICAM1 expression;Medical Oncology;2022-11-09